Navigation Links
An Effective Drug Identified for Shoulder Pain

According to the study conducted by Theodore Blaine, M.D., assistant professor of orthopaedic surgery at Columbia University Medical Center and an attending// surgeon at New York-Presbyterian Hospital sodium hyaluronate, a drug that is FDA-approved for osteoarthritis of the knee, is also effective for shoulder pain.

This study was mainly conducted after the rise in safety concerns surrounding Vioxx and other Cox-2 inhibitors. After that people went for surgery or took Advil which are two extremes.

The study was presented at the American Academy of Orthopaedic Surgeons annual meeting in Chicago. FDA approved the drug's use in treating knee pain after it showed a50% success during the trail period. At present the FDA is currently reviewing the results in shoulder pain. Chronic shoulder pain is a common problem that is very difficult to treat.

According to the National Institute of Musculoskeletal and Skin Diseases, shoulder problems are experienced by 1.5 million people. The pain can be caused by a variety of problems, including osteoarthritis or rotator cuff tears. Sodium hyaluronate is a vital building block of normal cartilage.

It is marketed under the name Hyalgan by Sanofi Aventis. The participants of the study had previously tried nonsurgical clinical interventions like physical therapy, steroid injection, and oral pain medications but the pain persisted. The study patients received an x-ray of the shoulder to confirm the diagnosis of osteoarthritis and rule out other causes of the pain. The 602 patients were divided into three groups.

One group received five injections of the drug over six months. A second group received three injections, followed by two saline injections, and the third group received just a placebo of five saline injections. They were observed for a period of six months. Then the patients were asked to record their level of pain on a scale of one to 100. Patients with osteoarthritis who rec eived sodium hyaluronate saw the greatest decrease in their pain scores, of 35 in six months.

The patients in the second group rated the pain around 37. The patients who received saline also saw a decrease, to around 43. The author says that the improvement in the saline group could be the result of the placebo effect. No safety concerns or side effects were seen during the study.


'"/>




Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process ... in power plant water and steam. , Chlorides and sulfates cause pitting and ... to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels ...
(Date:3/28/2017)... Florida (PRWEB) , ... March 28, 2017 , ... The ... Corp to raise money to for the Toys for Tots Literacy Campaign at their ... budget in excess of $70 billion, the U.S. ranks at number 14 internationally in ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... VICTORIA and TORONTO , ... Canada,s leading full service medical device development ... Group, the visionary Toronto -based medical ... entity will better serve medtech companies throughout ... increased resources and experienced medical device talent spanning the ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: